80 related articles for article (PubMed ID: 27229710)
1. Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.
Yamamoto T; Kadoya N; Takeda K; Matsushita H; Umezawa R; Sato K; Kubozono M; Ito K; Ishikawa Y; Kozumi M; Takahashi N; Katagiri Y; Onishi H; Jingu K
Radiat Oncol; 2016 May; 11():72. PubMed ID: 27229710
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS).
Siva S; Louie AV; Kotecha R; Barber MN; Ali M; Zhang Z; Guckenberger M; Kim MS; Scorsetti M; Tree AC; Slotman BJ; Sahgal A; Lo SS
Lancet Oncol; 2024 Jan; 25(1):e18-e28. PubMed ID: 38181809
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 5 Fraction Stereotactic Body Radiation Therapy (SBRT) for Osseous Renal Cell Carcinoma Metastases.
Dove APH; Wells A; Gong W; Liu D; Kirschner AN
Am J Clin Oncol; 2022 Dec; 45(12):501-505. PubMed ID: 36413679
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for inoperable patients with renal carcinoma.
Kotzki L; Udrescu C; Lapierre A; Badet L; Rouviere O; Paparel P; Chapet O
Fr J Urol; 2024 Mar; 34(2):102575. PubMed ID: 38364353
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy options in kidney cancer.
Zaorsky NG; Louie AV; Siva S
Curr Opin Support Palliat Care; 2023 Dec; 17(4):308-314. PubMed ID: 37877449
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy (SBRT): A new treatment option in renal cancer.
Couñago F; López-Campos F
Actas Urol Esp (Engl Ed); 2024 May; 48(4):260-261. PubMed ID: 37984716
[No Abstract] [Full Text] [Related]
7. Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma.
Gaudreault M; Hardcastle N; Jackson P; McIntosh L; Higgs B; Pryor D; Sidhom M; Dykyj R; Moore A; Kron T; Siva S
Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38679212
[TBL] [Abstract][Full Text] [Related]
8. Late Changes in Renal Volume and Function after Proton Beam Therapy in Pediatric and Adult Patients: Children Show Significant Renal Atrophy but Deterioration of Renal Function Is Minimal in the Long-Term in Both Groups.
Li Y; Mizumoto M; Nitta H; Fukushima H; Suzuki R; Hosaka S; Yamaki Y; Murakami M; Baba K; Nakamura M; Ishida T; Makishima H; Iizumi T; Saito T; Numajiri H; Nakai K; Kamizawa S; Kawano C; Oshiro Y; Sakurai H
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730586
[TBL] [Abstract][Full Text] [Related]
9. Adding Stereotactic Radiation to the Multidisciplinary Armamentarium for Localized Renal Cell Carcinoma: Ready for Primetime? : An Editorial Regarding a Recent 5-Year Efficacy and Safety Report of a Multicenter Cohort of Primary RCC Patients Treated with SABR.
Koehne EL; Psutka SP
Ann Surg Oncol; 2023 Nov; 30(12):6947-6949. PubMed ID: 37335349
[No Abstract] [Full Text] [Related]
10. Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?
Yang DX; Hannan R
Lancet Oncol; 2024 Mar; 25(3):267-269. PubMed ID: 38423040
[No Abstract] [Full Text] [Related]
11. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
[TBL] [Abstract][Full Text] [Related]
12. Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy.
Funayama S; Onishi H; Kuriyama K; Komiyama T; Marino K; Araya M; Saito R; Aoki S; Maehata Y; Nonaka H; Tominaga L; Muramatsu J; Nakagomi H; Kamiyama M; Takeda M
Technol Cancer Res Treat; 2019 Jan; 18():1533033818822329. PubMed ID: 30803362
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
Eur Urol Focus; 2019 Nov; 5(6):958-969. PubMed ID: 31248849
[TBL] [Abstract][Full Text] [Related]
14. Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer.
Ali M; Koo K; Chang D; Chan P; Oon SF; Moon D; Murphy DG; Eapen R; Goad J; Lawrentschuk N; Azad AA; Chander S; Shaw M; Hardcastle N; Siva S
Radiat Oncol; 2024 Feb; 19(1):23. PubMed ID: 38355495
[TBL] [Abstract][Full Text] [Related]
15. A Japanese registry study and systematic review of particle therapy for renal cell carcinoma.
Ishikawa H; Arimura T; Maruo K; Kawamura H; Toyama S; Ogino T; Okimoto T; Murakami M; Sato Y; Nishioka K; Araya M; Ohba H; Umehara K; Aoyama H; Obara W; Azuma H; Tsuji H; Sakurai H
J Radiat Res; 2023 Jun; 64(Supplement_1):i41-i48. PubMed ID: 37045797
[TBL] [Abstract][Full Text] [Related]
16. Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report.
Ishikawa Y; Yamamoto T; Umezawa R; Takahashi N; Takeda K; Suzuki Y; Jingu K
J Med Case Rep; 2022 Oct; 16(1):353. PubMed ID: 36184609
[TBL] [Abstract][Full Text] [Related]
17. Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma.
Haroon M; Sathiadoss P; Hibbert RM; Jeyaraj SK; Lim C; Schieda N
Abdom Radiol (NY); 2021 Nov; 46(11):5386-5407. PubMed ID: 34245341
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy and Renal Cell Carcinoma: A Continuing Saga.
Spyropoulou D; Tsiganos P; Dimitrakopoulos FI; Tolia M; Koutras A; Velissaris D; Lagadinou M; Papathanasiou N; Gkantaifi A; Kalofonos H; Kardamakis D
In Vivo; 2021; 35(3):1365-1377. PubMed ID: 33910814
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiotherapy for kidney cancer: a 10-year experience from a single institute.
Yamamoto T; Kawasaki Y; Umezawa R; Kadoya N; Matsushita H; Takeda K; Ishikawa Y; Takahashi N; Suzuki Y; Takeda K; Kawabata K; Ito A; Jingu K
J Radiat Res; 2021 May; 62(3):533-539. PubMed ID: 33866363
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
